DJIA 17,804.80 0.00 0.00%
NASDAQ 4,765.38 0.00 0.00%
S&P 500 2,070.65 0.00 0.00%
market minute promo

ZIOPHARM Oncology (NASDAQ: ZIOP)



company name or ticker

Strength Seen in ZIOPHARM Oncology (ZIOP): Stock Up 11.8% - Tale of the Tape

ZIOPHARM (ZIOP) Shares March Higher, Can It Continue? - Tale of the Tape

ZIOPHARM (ZIOP) Shares March Higher, Can It Continue? - Tale of the Tape

Why Sinovac Biotech, Burlington Stores, and ZIOPHARM Oncology Are Today's 3 Best Stocks

The S&P makes up nearly all of yesterday's lost ground, while Sinovac, Burlington, and ZIOPHARM all rise by double digits.

Investors' Radars Failed to Catch ZIOPHARM (ZIOP), Has Yours? - Tale of the Tape

Investors' Radars Failed to Catch ZIOPHARM (ZIOP), Has Yours? - Tale of the Tape

Following The Smart Money: The Small Cap Biotech Investments Of Randal J. Kirk

Why ZIOPHARM (ZIOP) is Poised to Beat Earnings Estimates? - Tale of the Tape

Surging Earnings Estimates Signal Good News for ZIOPHARM (ZIOP) - Tale of the Tape

Why ZIOPHARM Oncology, Inc. Zoomed Today

Is this meaningful or just another movement?

The 5 Most Hated Biotechs: Myraid, Sarepta, Questcor, Ziopharm, and MannKind

Myraid Genetics, Sarepta Therapeutics, Questcor Pharmaceuticals, Ziopharm Oncology, and MannKind top the list of the most shorted biotechs.

4 Stocks Under $10 Making Big Moves

See More Articles...